Obstetrics & Gynecology · Wallingford, CT
NPI
1437168457
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
185 Center St, Suite H
Wallingford, CT, 06492
Phone (203) 284-1060
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,190
148 services
Medicare patients, 2024
70
Average age 69
Drug cost, 2024
$6,361
185 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marlene L Waradzin was code 96127 (behavioral health services), 47 times for 47 patients. In total Marlene L Waradzin billed 148 services in 13 codes, and Medicare paid $7,190.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96127 Behavioral Health Services | Office | 47 | 47 | $3.28 | $154 |
| 99214 Office E&M - Established | Office | 46 | 46 | $87.86 | $4,042 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 15 | 15 | $42.80 | $642 |
By year: 2022 $8,248 for 149 services; 2023 $7,831 for 152 services; 2024 $7,190 for 148 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marlene L Waradzin prescribed most often to Medicare patients was Clotrimazole-Betamethasone (Clotrimazole/Betamethasone Dip), with 31 prescriptions and refills. In total Marlene L Waradzin wrote 185 Medicare prescriptions that cost $6,361.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 31 | 31 | 19 | $697 |
| Medroxyprogesterone Acetate Generic | 13 | 32 | Under 11 | $294 |
| Nylia Norethindrone-Ethin. Estradiol | 13 | 13 | Under 11 | $156 |
| Valacyclovir Valacyclovir Hcl | 12 | 12 | Under 11 | $103 |
Brand drugs: 11 claims; generic drugs: 174 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marlene L Waradzin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.